[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

The Oncology Institute Inc (TOI)

The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 507,044
  • Shares Outstanding, K 98,839
  • Annual Sales, $ 502,730 K
  • Annual Income, $ -60,610 K
  • EBIT $ -26 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.39
  • Price/Sales 0.96
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.02 on 05/07/26
  • Next Earnings Date 08/06/26 [AMC]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Options Overview Details

View History
  • Implied Volatility 84.30% (-5.58%)
  • Historical Volatility 68.80%
  • IV Percentile 8%
  • IV Rank 4.62%
  • IV High 481.17% on 02/09/26
  • IV Low 65.07% on 07/23/26
  • Expected Move (DTE 14) 0.55 (10.77%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 105
  • Volume Avg (30-Day) 2,237
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 49,467
  • Open Int (30-Day) 46,805
  • Expected Range 4.58 to 5.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 1
  • High Estimate $-0.07
  • Low Estimate $-0.07
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) +53.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.70 +9.15%
on 07/28/26
6.67 -23.09%
on 07/14/26
-0.15 (-2.84%)
since 07/02/26
3-Month
3.71 +38.27%
on 05/07/26
6.67 -23.09%
on 07/14/26
+1.08 (+26.67%)
since 05/01/26
52-Week
2.32 +121.12%
on 02/13/26
6.67 -23.09%
on 07/14/26
+1.40 (+37.53%)
since 08/01/25

Most Recent Stories

More News
The Oncology Institute Rebrands Into Starling Oncology While Its Balance Sheet Gets a Second Life

Barchart Research What to Expect from TOI Earnings TOI Generated August 5, 2026 Current Price $5.13 EPS Estimate $$-0.07 Consensus Rating Moderate Buy Average Move 13.55% The Oncology Institute Rebrands...

TOI : 5.13 (+5.56%)
The Oncology Institute Rebrands as Starling Oncology

CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call

CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity

CERRITOS, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, announced today that it has...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference

CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Yale...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference

CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich,...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
Oncology Institute Q1 Earnings Call Highlights

Oncology Institute (NASDAQ:TOI) reported a strong start to 2026, with first-quarter revenue rising 41% year over year as the company expanded value-based care arrangements and posted record specialty pharmacy...

TOI : 5.13 (+5.56%)
The Oncology Institute Reports First Quarter 2026 Financial Results

CERRITOS, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)
The Oncology Institute Reports Tomorrow With Profitability Still More Promise Than Pattern

Barchart Research What to Expect from TOI Earnings TOI Generated May 6, 2026 Current Price $3.80 EPS Estimate $$-0.07 Consensus Rating Moderate Buy Average Move 16.34% The Oncology Institute Reports Tomorrow...

TOI : 5.13 (+5.56%)
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call

CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release...

TOIIW : 0.0490 (-2.00%)
TOI : 5.13 (+5.56%)

Business Summary

The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 5.51
2nd Resistance Point 5.33
1st Resistance Point 5.23
Last Price 5.13
1st Support Level 4.95
2nd Support Level 4.77
3rd Support Level 4.67

See More

52-Week High 6.67
Last Price 5.13
Fibonacci 61.8% 5.01
Fibonacci 50% 4.49
Fibonacci 38.2% 3.98
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.